ICER Finalizes Updates to Value Assessment Framework
The Institute for Clinical and Economic Review (ICER) on Jan. 31 published an updated version of its value assessment framework [...]
SWHR’s Kocsis: Women Matter in Value Assessments
The National Pharmaceutical Council (NPC) recently sat down with the Society for Women's Health Research (SWHR) Vice President of Public [...]
NPC: No ‘Best’ Framework for Value Assessment
The National Pharmaceutical Council (NPC) in a recent report found that out of seven value assessment frameworks, there was no [...]
What Do Value Assessments Miss? Rethinking Value Using New Health Economics Evidence.
Dr. Patti Peeples, CEO and Founder of HealthEconomics.Com, recently sat down with Dr. Anupam Jena, Scientific Advisor, Precision Xtract, to discuss his latest research that expands the definition and measurement of value of novel therapies by using new health economics evidence.